Covina, United States: Intraosseous Infusion Device Market, By Product Type (FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, FAST Responder, Fastx Device, and NIO), By Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), By Route Of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head Of Humerus), By End User (Hospitals, Emergency Medical Services, Ambulatory Surgical Centers, and Cardiac Care Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Trends, Analysis and Forecast till 2029
Intraosseous Infusion Device Therapeutics Market Outlook
- Market Value 2020: US$ 3.7 Bn
- Market Value Estimation 2029: US$ 7.2 Bn
- CAGR: 7.5%
The vascular system can quickly and efficiently receive vital fluids and drugs through intraosseous infusion. The venous system is accessed through the bone marrow with intraosseous infusion (IO), as opposed to intravenous access (IV), which uses a peripheral vein. There are many devices that can be used for intraosseous infusion, including the FAST1 Device, Dieckmann Modified Needle, BIG Device, EZ-IO Device, Jamshidi Needle, Fastx Device, and NIO. The most efficient and quick method of treating many disorders is through the vascular system. The humerus, tibia, and sternum are the three primary sites for intraosseous access.
Top News relating to Industry, Innovation:
- In October 2013- Teleflex Incorporated announced that it has entered into a definitive agreement to acquire privately-held Vidacare Corporation, the leading provider of intraosseous (IO), or inside the bone, access devices.
- On April 3, 2017- Teleflex Incorporated completed the acquisition of Pyng Medical, a medical device company that developed and marketed sternal intraosseous infusion products, which complements the Teleflex Incorporated’s anesthesia product portfolio.
Are you a start-up willing to make it big in business? Grab an exclusive PDF brochure for this report:-
@ https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/1659
Ask For Sample Report:-
@ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/1659
Key Segmentation of the Intraosseous Infusion Device Therapeutics market:
The global intraosseous infusion device market accounted for US$ 3.7 billion in 2020 and is estimated to be US$ 7.2 billion by 2029 and is anticipated to register a CAGR of 7.5%. The market report has been segmented on the basis of product type, technology, route of administration, end user, and region.
- Depending upon product type, the FAST Responder segment is projected to grow at highest CAGR over the forecast period due its fast and effective treatment
- Depending upon the technology, the Battery Powered Driver segment is projected to register highest share of the market due to its easy usage and less risk and more accuracy while doing the procedure.
- In terms of route of administration, the Head of Humerus route of administration segment is projected to witness a significant CAGR over the forecast period as they provide a quick, easy to use, and dependable route for administration of all resuscitation and anesthetic drugs.
- By end user, the emergency medical services segment accounted for the majority market share and dominate the market. Pre-hospital emergency care is referred to as emergency medical services (EMS), which is constituted by ambulances or mobile medical services. The high success rates of intraosseous infusion in emergency cases will propel the growth potential of this market’s segment.
- By region, North America dominates the global intraosseous infusion device market in terms of revenue as compared to other regions. The market is boosting in this region due to increased cases of cardiovascular diseases, trauma, vascular related diseases. Further the advancement in the technology, availability of the product and the expert techniques and medical staff are driving the market. The second largest intraosseous infusion device market is in the Asia Pacific region.
The Intraosseous Infusion Device Therapeutics Market Report mentions the following promising regions:
- North America – U.S., Canada
- Europe – UK, Germany, Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific – Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
- Latin America – Brazil, Mexico, Argentina, Rest of Latin America
- Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Grab Special Discount Requests:
@ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/1659
Top-tier significant players:
The prominent player operating in the global Intraosseous Infusion Device Therapeutics market includes Pyng Medical Corp., Biopsybell, Cook Medical Incorporated, PAVmed, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson.
Premium Report offers:
- Assessments of market share for the regional and national segments
- A description of the business, including its goals, finances, and most recent advancements.
- In addition to a comprehensive analysis of market share, the report contains data on significant drivers, restraints, and opportunities.
- The market power of consumers and suppliers is demonstrated via Porter’s five forces study.
Links to related reports@
About Prophecy Market Insights
Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
Contact Us:
Sales
Prophecy Market Insights
1 860 531 2701
Email– sales@prophecymarketinsights.com
Website– www.prophecymarketinsights.com
